	Development of a Combined Risk Factors Prediction Model for Esophageal Squamous Cell Carcinoma: A Secondary Analysis of the Linxian Nutrition Intervention Trial Cohort. Res Sq Yang H, Shi J, Wang J, Fan J, Zhang S, Liu Y, Xu H, Sewram V, Zhang J, Zhao F, Qiao Y, Abnet CC. PMID: 42466406 [PubMed]
	The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review). Int J Oncol Zhao Y, He C, Chen K, Sun N, He R, Li G. PMID: 42464658 [PubMed - indexed for MEDLINE]
	Lessons learned: use of 24-hour ambulatory esophageal and gastric pH monitoring and its implications for proton pump inhibitor use in cancer patients requiring oral oncologic therapies. Dis Esophagus Triadafilopoulos G. PMID: 42462210 [PubMed - indexed for MEDLINE]
	Noble Metal-Metal Oxide Nanohybrids as a High-Performance LDI-MS Matrix for Machine Learning-Driven Metabolic Diagnosis of Esophageal Cancer. Anal Chem Wang C, Shi M, Peng P, Qu Y, Yu X, Bu Y, Fu H, Jin Z, Zhang X, Chen J, Nie Z. PMID: 42461696 [PubMed - as supplied by publisher]
	Immune checkpoint inhibitors plus trastuzumab and chemotherapy for the treatment of advanced HER2-positive gastric and gastroesophageal junction cancers: a systematic review and meta-analysis. Front Immunol Zhan H, Zhang H, Tian C, Liu P, Sun W. PMID: 42459656 [PubMed - indexed for MEDLINE]
	Tumor microenvironment-oriented HNGCIscore identifies immunotherapy-sensitive subgroups in ICI retreatment of HER2-negative advanced gastric cancer. Front Oncol Song X, Wu Y, Zhu Y, He Y, Shi J, Ren K, Gao C. PMID: 42459296 [PubMed]
	Risk of Postoperative Bleeding in Esophageal Endoscopic Submucosal Dissection for Squamous Cell Carcinoma in Patients on Antiplatelet Therapy: A Multicenter Retrospective Study in Japan. Dig Endosc Hirai R, Yamamoto Y, Yasuda T, Yanagita T, Iwatsubo T, Tani Y, Yoshii S, Sakata Y, Iwagami H, Nozaka T, Uozumi T, Masui Y, Konishi J, Shiotsuki K, Kido K, Kano Y, Ohata K, Matsuura N, Dobashi A, Yoda Y, Kushida S, Yamamoto Y, Urabe Y, Yoshio T, Abe S, Kadota T, Takizawa K, Yano T, Ono H. PMID: 42457578 [PubMed - indexed for MEDLINE]
	Opium and opioid use and cancer risk: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Res Commun Semnani K, Ghoreshi B, Mehrpour O, Sobhani S, Esmaeili M, Alirezaei A, Chaghamirzayi P, Mahdavi-Gorabi A, Rezaei N, Djalalinia S, Qorbani M. PMID: 42456280 [PubMed - as supplied by publisher]
	Effectiveness and safety of carbon ion radiotherapy for stage III non-small cell lung cancer: a single-center retrospective study. Front Oncol Zhao X, Wang B, Zhang Y, Li P, Liang X, Gong Q, Tian L, Qin T, Chen X, Li Z, Nie P, Zhang Y, Ye Y. PMID: 42453889 [PubMed]
	Smoking-attributable gastrointestinal cancer burden in Brazil, Russia, India, China and South Africa (BRICS) and Associated Economies: A Global Burden of Disease study analysis 1990-2023. Tob Prev Cessat Jiang W, Wang Y, Cheng R. PMID: 42453357 [PubMed]
	Pulses and Cancer Outcomes: A Scoping Review of Human Studies on Risk Reduction. Nutrients Mohd Nawi MN, Ibrahim N, Bee Yong T, Abd Rashed A, Rmt Balasubramaniam V. PMID: 42451068 [PubMed - indexed for MEDLINE]
	Cancer Diagnoses and Deaths in Hungary, 2011-2023: Nationwide Trends Before, During, and After the COVID-19 Pandemic. Cancers (Basel) Kiss Z, Szabó TG, Maráz A, Rokszin G, Horváth Z, Nagy P, Abonyi-Tóth Z, Kovács V, Surján O, Barcza Z, Kenessey I, Wéber A, Wittmann I, Molnár GA, Neuhauser N, Darida M, Köveskúti I, Tamás RB, Bogos K, Moldvay J, Gálffy G, Tamási L, Müller V, Krasznai ZT, Pápai-Székely Z, Baltás E, Gyulai RP, Boér K, Holló P, Kocsis J, Máté S, Nikolényi A, Novák Z, Rubovszky G, Dank M, Vokó Z. PMID: 42449573 [PubMed]
	Development and internal validation of a dynamic Prealbumin-Immune-Inflammation-NLR Prognostic Score (PINPS) for esophageal squamous cell carcinoma treated with immune checkpoint inhibitors: a retrospective cohort study. BMC Cancer Ding H, Hao S, He G, Zhao K, Ling Y. PMID: 42449264 [PubMed - as supplied by publisher]
	Quality of Life Endpoints in Advanced Gastrointestinal Cancer Trials: Systematic Review of Inclusion, Challenges, and Implications (2020-2024). Clin Oncol (R Coll Radiol) Kalantri S, Kelley B, Freeman JQ, Akhiwu TO, Redman R. PMID: 42447620 [PubMed - as supplied by publisher]
	Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: a single-arm phase II clinical trial. Future Oncol Liu T, Dan X, Li Q, Wang P, Chen Y, Tian J, Lin Z, Hu Y, Shi H, Ding Z. PMID: 42446091 [PubMed - as supplied by publisher]
	Bifidobacterium animalis subsp. lactis V9 improves quality of life in advanced gastrointestinal cancer through gut microbiota-metabolite modulation. ISME Commun Yang L, Liu Y, Li J, Lv J, Zhang Q, Cong M, Shi H, Zhang H. PMID: 42445733 [PubMed]
	A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma. Transl Cancer Res Xiao WT, Wu SQ, Han YR, Song JH, He JY. PMID: 42445408 [PubMed]
	DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation. Transl Cancer Res Muad YA, Zhang L, Peng W, Ye L. PMID: 42445401 [PubMed]
	Accuracy of machine learning in detecting lymph node metastasis of esophageal cancer: a systematic review and meta-analysis. Transl Cancer Res Chen J, Weng J, Lin X. PMID: 42445376 [PubMed]
	Systemic Inflammation Response Index, Albumin, and Hemoglobin-Albumin-Lymphocyte-Platelet Score for Stage-Stratified Esophageal Cancer Discrimination: A Retrospective Case-Control Study. Cancer Manag Res Li Y, Cui Y, Liu M, Zhang J, Liu Y. PMID: 42445223 [PubMed]

Articles 1 - 20 / 39313

Page 1 of 1966



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy